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Editorial
Biomaterials, Cells, and Patho-physiology: Building Better Organoids and On-Chip Technologies
Three-dimensional ex vivo cellular cultures, engineered through
cellular self-assembly under natural extracellular matrix (ECM) cues or
through a biomaterial-based directed assembly, have emerged as
powerful in vitro technologies for a wide range of biomedical applica-
tions. The ex vivo tissue models imitate one or more physiologically-
relevant features and functions of target organs. The on-chip technol-
ogies and materials-based organoids have garnered enormous mo-
mentum, in the past few years, for their applications in disease mod-
eling, mammalian tissue development, drug screening, and therapy
design or even organ replacement. This “Organoids on a Chip” special
issue focuses on the ex vivo tissue constructs in a dish and on-chip
format for a wide range of tissues and organ systems, including liver,
heart, muscle, lung, musculoskeletal, and immune system. The special
issue presents a collection of original research articles and review
perspectives from experts in their respective fields.
In this issue, Milica Radisic and colleagues review recent advances
in the engineering of functional in vitro tissue model systems for
studying the pathophysiology of cardiovascular diseases and drug
screening applications. They provide an overview of small and large in
vivo animal models and discuss 3D in vitro tissue engineered as well as
on-chip models for cardiovascular diseases research. Their article fur-
ther discussed the opportunities of engineered in vitro tissue model
systems for the discovery of novel therapeutic targets for the treatment
of cardiovascular diseases. Nasim Annabi and colleagues review recent
advancements in the development of smart biomaterials, biofabrication
techniques, and stem cell engineering, aimed at recapitulating cardio-
vascular function at the tissue- and organ levels. They provide a per-
spective on the clinical relevance of the existing approaches and future
development towards personalized targeted therapeutics.
In a research article, Claudia Fischbach and colleagues report the de-
velopment of a 3D tissue system, using mineralized collagen-I hydrogel, to
mimic collagen matrix in bone and to gain a better insight on the biolo-
gical mechanisms of breast cancer bone metastasis. The outcome of this
work demonstrated reduced cancer cell adhesion and alerted migration
profile, highlighting the influence of mineralization of collagen matrix on
the biological response of cancer cells through integrin-mediated me-
chanotransduction. Within the space of pathophysiological tumor models,
Yanan Du and team report the development of a 3D micro-tumor array
system for anti-cancer drug screening. The proposed high-density 3D
micro-tumor model was established based on dispensing target cells into
porous gelatin micro-scaffold within a 384-well system. They utilized
primary cells from patient-derived xenografts (PDX) or patient biopsies to
test the reliability of their platform in chemotherapeutic screening. Their
findings demonstrated better recapitulation of in vivo drug efficacy, using
the 3D micro-tumor array system, as compared to 2D conventional assays.
Shyni Varghese and colleagues further review the recent developments in
the synthesis of bioinspired materials for bone tissue engineering and
disease modeling applications. Their review article specifically highlights
the use of bioinspired materials, such as calcium phosphate or collagen-
based matrices, to mimic the biophysical and biochemical cues of the
native bone environment. The article further discussed the engineering of
organ-on-chip systems for recapitulation of bone pathologies and drug
screening applications.
In this issue, in a research article, Ankur Singh and colleagues report
the development of a designer hydrogel-based synthetic immune tissue
(in a dish) that shows the ability to generate high-affinity antigen-specific
antibody formation. They report a maleimide (MAL)-functiona-
lized polyethylene glycol (PEG)-based designer immune tissues that
modulate B cell differentiation and enriches antigen-specific germinal
center B cells in the presence of T-cell like signals. The ex vivo antigen-
specific platform technology offers its use in scientific understanding of
immunobiology, matrix immunology, and in biotechnology applications,
ranging from the antigen testing, vaccine development, and generation of
antibodies against diseases. On the other hand, Thomas Webster and
colleagues reviewed the recent developments of in vitro platform tech-
nologies and ex vivo systems for modeling of infectious diseases. In their
article, they discuss the advantages and limitations of currently available
biofilm model systems, 3D organoid, and microfluidic models, as well as
ex vivo and in vivo models which have been utilized for infection studies.
In a new research article, Roger Kamm and colleagues develop a 3D
vascularized microfluidic model and provide evidence of direct engage-
ment between human monocytes and tumor cells in a 3D vascular-
ized microfluidic model. They report that inflammatory, but not patrol-
ling, monocytes rely on actomyosin-based motility. This study brings
important insight into the role of monocytes in cancer cell extravasation
and sheds light on the metastatic cascade.
In a series of research and review articles, Christine Schmidt, Brendan
Harley, and Mehdi Nikkhah describe ex vivo models of the brain system.
Schmidt and colleagues provide an overview of the technologies related
to ex vivo models and lab-on-a-chip devices for studying the regenera-
tion of the brain, spinal cord, and peripheral nerve tissues. Importantly,
they also review current commercial products that mimic diseased and
normal neural tissues and discuss the future directions in this field. In a
research article, Harley and colleagues describe how perivascular signals
alter global gene expression profile of glioblastoma and response to te-
mozolomide in a gelatin hydrogel-based tumor model. By combining the
results of an engineered hydrogel and RNA sequencing, they further
demonstrate the upregulation and downregulation of genes related
to angiogenesis, DNA damage repair, extracellular matrix remodeling
etc. under specific disease conditions and perivascular niche. Nikkhah
and colleagues posit that glioma stem cell populations in glioblastoma
are highly tumorigenic, invasive, and resistant to several forms of
therapy. They developed a 3D organotypic microfluidic platform, in-
tegrated with hydrogel-based biomaterials, to mimic the glioma stem cell
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vascular niche and studied the influence of vascular cells on patient-
derived glioma stem cells. Their model further presents for development
of future therapeutic strategies tailored toward disrupting key molecular
pathways involved in glioma stem cell regulatory mechanisms.
David Kaplan and colleagues reported synthesis and characteriza-
tion of protein-based silk-collagen composite biomaterials, with en-
hanced biophysical properties, for engineering of a 3D full thickness
human skin system. Their tissue model system provided a suitable en-
vironment for multi-culture of cells, including neurons and immune
cells, demonstrating its utility as a reliable substitute to animal models,
for research on skin diseases and drug discovery.
Cherie Stabler and Edward Phelps provided important insight into ex
vivomodels related to diabetes. In general islet microphysiological systems
are limited and attributed to their poor cell survival and function outside
of the body. Stabler and colleagues sought to recapitulate the in vivo peri-
islet niche using decellularized extracellular matrix hydrogels. Sourcing
from porcine bladder, lung, and pancreas tissues, they engineered 3D
hydrogels and validated using both rodent and human pancreatic islets.
These supportive 3D physiomimetic bioadhesive hydrogels can be lever-
aged within microfluidic platforms for the long-term culture of islets.
Phelps and colleagues, on the other hand, discuss the pathophysiology of
type-1 involving microenvironments, immune cell – islet cell interactions,
and the eventual breaking of immune tolerance leading to beta cell death.
They review recent advances in this field and suggest ways to synergize
systems to model and observe the pathophysiology of autoimmune dia-
betes with bioengineered therapeutic strategies.
James Hudson demonstrated the development of a culture system to
engineer ex vivo human skeletal micro muscles (hμMs). The engineered
hμMs comprised of bundles of striated and functional myofibres, which
responded appropriately to electrical stimulation. They stimulated hμM to
recapitulate known features of exercise training including myofibre hy-
pertrophy and increased expression of metabolic proteins. The engineered
platform enables high-throughput studies of human skeletal muscle
biology and exercise physiology. On a similar line, Tony Mikos and col-
leagues comprehensively reviewed recent advances in the development of
muscle-on-a-chip technologies for drug screening and studying muscular
diseases. They reviewed current muscular disease models and the use of
microfluidic platforms to understand disease pathology and high
throughput screening of therapeutics for muscular myopathies.
Nenad Bursac and his team study the effect of electrical stimulation
on the maturation of 3D tissue-engineered human muscles (myobundles).
They showed that stimulation frequency and duration had effects on
myobundle size, sarcomeric protein abundance, calcium transient ampli-
tude, and myotube hypertrophy. In addition, electrically stimulated
myobundles demonstrated a decrease in fatigue resistance and an in-
crease in glycolytic and fatty acid metabolic flux. This platform can be
used as an advanced in vitro model of human skeletal muscle with im-
proved structure, function, maturation, and metabolic flux.
In this issue, Celeste Nelson and his team reviewed the application
of 3D culture models for studying branching morphogenesis of mam-
mary glands and the mammalian lung in both normal tissue develop-
ment and disease manifestation. In this review article, they summarized
the limitation of 3D culture models used for understanding the me-
chanisms of branching in the mammary gland and mammalian lung and
provided their insight on the potential future directions for engineering
the next generation of 3D culture models for studying tissue morpho-
genesis. On the other hand, Ali Khademohsseini and his colleagues re-
viewed recent advances in engineering ex vivo vascularized tissue
constructs using advanced 3D bioprinting techniques. These technolo-
gies can be used to form vascularized tissue constructs with vascu-
latures ranging from capillaries to large blood vessels. They discussed
how these advanced technologies can be implemented for patterning
proangiogenic factors to maintain the long-term, stimuli-controlled
formation of new capillaries. The development of new technologies to
print complex 3D vascular networks may offer an opportunity to en-
gineer functional thick ex vivo tissue constructs.
It has been a pleasure and an honor to put this themed issue together.
The editors would like to thank all the authors, Editor-in-Chief Kam W.
Leong, and to the Elsevier team for their generous time. We believe that
this collection of reviews serves not only as a testimony to the enormous
promise of ex vivo organoids and on-chip technologies but also as a
foundation for understanding the challenges and barriers for making
organotypic and body-on-chip platforms. We sincerely hope that the
biomaterials scientists, biomedical engineers, clinicians, and the life
sciences community will find inspiration from this collection and con-
tribute synergistic and transformative new ideas to further advance this
field for fundamental biological studies and targeted drug discoveries.
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